Suchergebnisse - "Sarilumab"

PubPharm (319)

81

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

82

Management of hepatitis B virus reactivation due to treatment of COVID-19

enthalten in: Hepatology international | 2022

von Yip, T. | Gill, M. | Wong, G. | +1

83

Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care : Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care - SARICOVID

enthalten in: WHO International Clinical Trials Registry Platform | 2022

84

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation : the SARICOR Randomized Clinical Trial

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Merchante, N. | Cárcel, S. | Garrido-Gracia, J. | +17

85

A guide to immunotherapy for COVID-19

enthalten in: Nature medicine | 2022

von van de Veerdonk, F. | Giamarellos-Bourboulis, E. | Pickkers, P. | +12

86

Immunotherapy of COVID-19 : Inside and Beyond IL-6 Signalling

enthalten in: Frontiers in immunology | 2022

von Zizzo, G. | Tamburello, A. | Castelnovo, L. | +5

87

The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients

enthalten in: Molecular and cellular biology | 2022

von McAleavy, M. | Zhang, Q. | Ehmann, P. | +14

88

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

enthalten in: Cytokine | 2022

von Kow, C. | Zaihan, A. | Ramachandram, D. | +1

89

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease : A pragmatic, embedded randomized clinical trial

enthalten in: PloS one | 2022

von Branch-Elliman, W. | Ferguson, R. | Doros, G. | +18

90

Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography : A case report

enthalten in: Medicine | 2022

von Abe, K. | Ishikawa, Y. | Fujiwara, M. | +5